Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Immunosuppression in IgA Nephropathy
NCT03468972Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Mar 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of corticosteroids, cyclophosphamide in IgA nephropathy (IgAN), sponsored by Yonsei University. Status: unknown.
02
Drugs
corticosteroidscyclophosphamide
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT03468972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03468972.